-
-
-
-
-
-
-
Motif Bio (MTFB) Announces FDA Acceptance of NDA with Priority Review for Iclaprim for Treatment of ABSSSI
-
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

